Carbubarb

Carbubarb
Clinical data
Trade names	Nogexan
Other names	Carbubarbital
ATC code	none;
Identifiers
	IUPAC name 2-(5-butyl-2,4,6-trioxo-1,3-diazinan-5-yl)ethyl carbamate;
CAS Number	960-05-4 ;
PubChem CID	13743;
ChemSpider	13148 ;
UNII	SIW4YR11ST;
ChEMBL	ChEMBL2104020 ;
CompTox Dashboard (EPA)	DTXSID70242076 ;
Chemical and physical data
Formula	C11H17N3O5
Molar mass	271.273 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCCCC1(C(=O)NC(=O)NC1=O)CCOC(=O)N;
	InChI InChI=1S/C11H17N3O5/c1-2-3-4-11(5-6-19-9(12)17)7(15)13-10(18)14-8(11)16/h2-6H2,1H3,(H2,12,17)(H2,13,14,15,16,18) ; Key:ZWGPHQZXAPWKOV-UHFFFAOYSA-N ;
	(what is this?) (verify)

Carbubarb (carbubarbital, trade name Nogexan) is a carbamate-substituted barbiturate derivative, which has sedative effects.^[1]

References

^ US patent 4428887, Tou, J. S. & Schleppnik, A. A., "Method of producing mono-substituted terminal diesters", issued 1984-01-31, assigned to Monsanto

This sedative-related article is a stub. You can help Wikipedia by expanding it.